Zoledronic acid (ZA) in the management of mesothelioma: qualitative nested study (Zol-A Trial)

A double-blind randomised controlled feasibility study was conducted to assess the recruitment and acceptability of ZA/placebo alongside chemotherapy in malignant pleural mesothelioma. A qualitative nested study was included in the study and was undertaken by our team.


Want to receive updates from the Mesothelioma UK Research Centre?